Med Page Today
MARCH 11, 2024
(MedPage Today) -- Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic drugs (AADs) had several-fold.
NOVARAD
MARCH 11, 2024
There's no denying it: burnout is a serious problem among physicians. Over 50% of radiologists say that they've experienced “long-term, unresolved, job-related stress leading to exhaustion, cynicism, detachment from job responsibilities, and lacking a sense of personal accomplishment.” The numbers are startling and point to the need for immediate action to address the high level of burnout among physicians.
HCPLive
MARCH 11, 2024
Patients in France with hemophilia A who switched their FVIII replacement treatment trended towards fewer bleeding events and articular non-bleeding events requiring hospitalization.
Society of Thoracic Surgeons - Congenital
MARCH 11, 2024
News Cardiovascular Infection on the Rise: New Multisociety Statement on Use of PET/CT and SPECT/CT for Evaluation KCummings Mon, 03/11/2024 - 08:11 4 min read
HCPLive
MARCH 11, 2024
Baseline kidney function, AKD severity, and post-AKD kidney function were identified as important factors for predicting outcomes in patients with acute kidney injury requiring dialysis.
Circulation
MARCH 11, 2024
Circulation, Ahead of Print. BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). The aim of this study was to investigate outcomes in patients with left main disease with and without diabetes undergoing PCI versus CABG.METHODS:Individual patient data were pooled from 4 trials (SYNTAX [TAXUS Drug-Eluting Stent Versus Coronary Artery Bypa
HCPLive
MARCH 11, 2024
A new study found older adults who are frail are less likely to engage in social interactions, which can cause them to lose social contact and create loneliness.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Becker's Hospital Review - Cardiology
MARCH 11, 2024
Big changes could be coming to cardiology thanks in part to the work of Jeffrey Kuvin, MD, co-executive director of the New York City-based Northwell Cardiovascular Institute and professor and chair of the department of cardiology New Hyde Park, N.Y.-based Northwell Health.
HCPLive
MARCH 11, 2024
Nearly a decade after becoming the first PCSK9 inhibitor to receive approval from the FDA, alirocumab (Praluent) has now received approval for pediatric patients with HeFH based on data from a phase 3 trial.
American College of Cardiology
MARCH 11, 2024
Many research studies have focused on evaluating the predictive ability of coronary artery calcium (CAC) scoring in cohorts primarily consisting of middle-aged individuals.
HCPLive
MARCH 11, 2024
Blauvelt discusses the impetus for his phase 2 trial looking at the ability to mitigate pivotal psoriasis memory T cells with risankizumab.
Science Daily - Heart Disease
MARCH 11, 2024
Doctors may be able to leverage the new insights to identify patients at greatest risk of having atherosclerotic plaques break free and cause heart attacks or strokes.
HCPLive
MARCH 11, 2024
New data from the Mayo Clinic show high BMI does not correlate with severe hidradenitis suppurativa in affected children and adolescents.
Science Daily - Heart Disease
MARCH 11, 2024
A new study reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholesterol that can otherwise cause damage to arteries. The findings suggest that the response to the onset of atherosclerosis begins in the liver.
DAIC
MARCH 11, 2024
VahatiCor, Inc., a med tech company dedicated to helping patients with persistent ischemic heart disease, has announced the treatment of the first patient with the A-FLUX Reducer System, a treatment for patients with angina or chest pain. Image courtesy: VahitiCor christine.book Mon, 03/11/2024 - 15:01 March 11, 2024 — VahatiCor, Inc. , a med tech company dedicated to helping patients with persistent ischemic heart disease, has announced the treatment of the first patient with the A-FLUX Reducer
HCPLive
MARCH 11, 2024
Another segment of Silverberg’s interview at AAD 2024 featured a discussion on safety data and the larger implications of these phase 3 findings for eczema management.
Becker's Hospital Review - Cardiology
MARCH 11, 2024
Discover the top 10 cardiac surgery hospitals in the world according to Newsweek's 2024 "World's Best Hospitals" list, with 7 based in the U.S.
HCPLive
MARCH 11, 2024
This interview at AAD featured a discussion with Silverberg on nemolizumab’s efficacy and safety at Week 48 among patients with moderate-to-severe atopic dermatitis.
American College of Cardiology
MARCH 11, 2024
In these panel discussions, host Andrea Price, MS, AACC brings together Marian Hawkey, RN and Misty Theriot, BSN to explore best practices related to structural heart disease.
HCPLive
MARCH 11, 2024
These study findings, presented at AAD 2024, were the results of a recent analysis conducted to assess long-term outcomes among patients with psoriasis.
Conquering CHD
MARCH 11, 2024
Summer camp. The very words conjure up images of bonfires, canoeing, and making lifelong friends. But for children with Congenital Heart Disease (CHD), the traditional camp experience might not be an option. Yet, the desire for connection, for belonging, remains just as strong. Thankfully, there are incredible summer camps designed specifically for kids with CHD.
HCPLive
MARCH 11, 2024
The submission could grant guselkumab its third indication, after being approved by the FDA for psoriasis and psoriatic arthritis.
Physiologically Speaking
MARCH 11, 2024
You can also find this podcast episode on Apple Podcasts. Dr. Tamara Hew-Butler ( @hyponaqueen ) is a podiatric physician and associate professor of Exercise and Sports Science at Wayne State University. She earned her PhD at the University of Cape Town, South Africa, where she studied and trained under the legendary sports scientist and physician Dr.
HCPLive
MARCH 11, 2024
A new study found how premiums for lower-cost plans in Georgia did not reduce enough to make up for the decrease in subsidies, causing people in middle class to have to pay more.
Physiologically Speaking
MARCH 11, 2024
You can find the audio-only version of this post here. Dr. Tamara Hew-Butler ( @hyponaqueen ) is a podiatric physician and associate professor of Exercise and Sports Science at Wayne State University. She earned her PhD at the University of Cape Town, South Africa, where she studied and trained under the legendary sports scientist and physician Dr.
HCPLive
MARCH 11, 2024
Iron deficiency marks more than a comorbidity in heart failure, with adverse manifestations, including anemia and a higher risk of mortality, influencing the clinical trajectory of patients with HFrEF.
American College of Cardiology
MARCH 11, 2024
The following are key points to remember from an American Heart Association Scientific Statement on neurodevelopmental outcomes for individuals with congenital heart disease, which includes updates in neuroprotection, risk-stratification, evaluation, and management.
HCPLive
MARCH 11, 2024
Findings reveal a 20% mortality rate in an Eastern European cohort, primarily due to cardiovascular diseases and linked to an absence of RASi use, among other factors.
American College of Cardiology
MARCH 11, 2024
The goal of the POST-PCI trial was to evaluate functional testing compared with standard of care among patients who underwent percutaneous coronary intervention (PCI) and had high-risk characteristics.
HCPLive
MARCH 11, 2024
In this segment of his AAD interview, Hamzavi discussed more about his team’s findings on upadacitinib as well as their implications and future in terms of research.
American College of Cardiology
MARCH 11, 2024
The Centers for Medicare and Medicaid Services (CMS) announced on March 9 a new opportunity to request advanced Medicare payments for clinicians impacted by the cyberattack and resulting claims disruptions with Change Healthcare. CMS will consider applications for accelerated payments for Medicare Part A providers and advanced payments for Part B suppliers.
HCPLive
MARCH 11, 2024
John H Stone, MD, MPH, discusses the recent clinician-authored white paper from the Alliance for Patient Access: "Addressing Access Barriers for IgG4-RD Patients.
Nature Reviews - Cardiology
MARCH 11, 2024
Nature Reviews Cardiology, Published online: 12 March 2024; doi:10.1038/s41569-024-01007-z Shoaran and Maffia recount how our understanding of the role of inflammation in atherosclerosis has evolved and highlight the study by Göran Hansson and colleagues that provided the first hint of the involvement of the adaptive immune response in atherosclerosis.
HCPLive
MARCH 11, 2024
Test your knowledge of the ACR's guideline for the management of gout with this quiz!
Circulation
MARCH 11, 2024
Circulation, Ahead of Print. Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular evaluations are crucial in pretransplantation assessments, but guidelines are lacking. This American Heart Association scientific statement summarizes the data on transplantation-related complications and provides guidance for the cardiovascular management throughout transplantation.
Hypertension Journal
MARCH 11, 2024
Hypertension, Ahead of Print. Background:The SSaSS (Salt Substitute and Stroke Study) has shown that use of a potassium-enriched salt lowers the risk of stroke, total cardiovascular events, and premature death. The effects on cause-specific cardiac outcomes are reported here.Methods:SSaSS was an unblinded, cluster-randomised trial assessing the effects of potassium-enriched salt compared with regular salt among 20 995 Chinese adults with established stroke and older age and uncontrolled hyperten
Frontiers in Cardiovascular Medicine
MARCH 11, 2024
Background Myasthenia gravis is a rare chronic autoimmune neuromuscular disorder mainly caused by autoantibodies to the nicotinic acetylcholine receptor. Cholesterol is an essential molecule that affects the distribution and proper functioning of this receptor. Several reports have described the potential worsening of myasthenia gravis in patients treated with statins.
Expert insights. Personalized for you.
130 
Let's personalize your content